Safety Analysis of Adjuvant Chemotherapy with Docetaxel Administered with or without Anthracyclines to Early Stage Breast Cancer Patients: Combined Results from the Asia- Pacific Breast Initiatives I and II. [electronic resource]
Producer: 20170119Description: 697-702 p. digitalISSN:- 2476-762X
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Breast Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Docetaxel
- Doxorubicin -- administration & dosage
- Epirubicin -- administration & dosage
- Female
- Follow-Up Studies
- Humans
- Longitudinal Studies
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neoplasm Staging
- Prognosis
- Prospective Studies
- Safety
- Survival Rate
- Taxoids -- administration & dosage
- Young Adult
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.